ReWalk Receives CE Mark For ReStore Exo-Suit For Stroke Rehabilitation
Israel-based exoskeleton company ReWalk Robotics Ltd. announced it received a CE mark for its next-gen ReStore Exo-Suit for stroke rehabilitation, paving the way into a larger patient population.
You may also be interested in...
ReWalk plans to use the proceeds to fund sales, R&D and reimbursement expenses related to its ReStore and Personal 6.0 devices as it continues to face negative effects of pandemic.
Attorneys with the law firm Dechert LLP expect the number of securities claims filed to rise in 2021 after a slide last year.
A snapshot of global medical device approvals captured during the past week in Medtech Insight's Approvals Tracker. This week’s approvals include the US FDA's approval of a panel-track supplement for TransMedics' OCS Lung system to preserve donor lungs that would not be salvageable using a traditional cold static system.